Sara Nik

Stock Analyst at HC Wainwright & Co.

(n/a)

# 4,851

Out of 5,126 analysts

4

Total ratings

n/a

Success rate

-42.98%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MBRX Moleculin Biotech	Maintains: Buy	$4 → $22	$4.31	+410.44%	3	Dec 11, 2025
	KTTA Pasithea Therapeutics	Initiates: Buy	$3	$0.73	+313.79%	1	Dec 8, 2025

Moleculin Biotech

Dec 11, 2025

Maintains: Buy

Price Target: $4 → $22

Current: $4.31

Upside: +410.44%

Pasithea Therapeutics

Dec 8, 2025

Initiates: Buy

Price Target: $3

Current: $0.73

Upside: +313.79%